-
Pulmatrix (PULM) Reports Q3 Loss of $0.24
-
Pulmatrix reports Q3 loss, seeks buyer for drug delivery assets
-
Pulmatrix (PULM) Reports Q2 Loss of $0.42
-
Pulmatrix (PULM) Reports Q1, Announces Divestment Plan for Assets
-
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pulmatrix, Inc. (PULM)
-
Pulmatrix (PULM) and Cullgen Announce Proposed Merger
-
Pulmatrix (PULM) Halted, News Pending
-
Pulmatrix (PULM) Reports Q3 Loss of $0.71

